Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2020 Filed May 7, 2020 21:17 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
GrantPhantom Stock · Derivative | 877 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000117 · certent-form4.xml · derivative · entry 1 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,451 Underlying: Phantom Stock · 877 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:14 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 1,719 | $22.82 | $39,218.99 |
DisclosureSEC source: 0000784199-20-000115 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,766 F1 · price: Reflects the price of $22.815 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:53 UTC |
Maier Dennis BVice President, Operations
|
Tax withholdingCommon Stock | 226 | $20.24 | $4,574.24 |
DisclosureSEC source: 0000784199-20-000087 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,668 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:52 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 2,674 | $20.24 | $54,121.76 |
DisclosureSEC source: 0000784199-20-000085 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,774 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:52 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000085 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,448 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:50 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 513 | $20.24 | $10,383.12 |
DisclosureSEC source: 0000784199-20-000083 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,692 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:50 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 4,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000083 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,205 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:48 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 292 | $20.24 | $5,910.08 |
DisclosureSEC source: 0000784199-20-000081 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,642 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:48 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000081 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,934 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:46 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 447 | $20.24 | $9,047.28 |
DisclosureSEC source: 0000784199-20-000079 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,051 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:46 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 3,390 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000079 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,498 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:43 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 373 | $20.24 | $7,549.52 |
DisclosureSEC source: 0000784199-20-000076 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,451 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:43 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000076 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,824 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:38 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 233 | $20.24 | $4,715.92 |
DisclosureSEC source: 0000784199-20-000074 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,006 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:38 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000074 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,239 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:37 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
Tax withholdingCommon Stock | 337 | $20.24 | $6,820.88 |
DisclosureSEC source: 0000784199-20-000072 · certent-form4.xml · nonDerivative · entry 1 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,451 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:18 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
Tax withholdingCommon Stock | 658 | $24.93 | $16,403.94 |
DisclosureSEC source: 0000784199-20-000069 · certent-form4.xml · nonDerivative · entry 2 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,387 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:18 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantCommon Stock | 3,714 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000069 · certent-form4.xml · nonDerivative · entry 1 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,045 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:15 UTC |
Maier Dennis BVice President, Operations
|
Tax withholdingCommon Stock | 411 | $24.93 | $10,246.23 |
DisclosureSEC source: 0000784199-20-000067 · certent-form4.xml · nonDerivative · entry 2 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,894 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:15 UTC |
Maier Dennis BVice President, Operations
|
GrantCommon Stock | 2,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000067 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,305 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:14 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 4,455 | $24.93 | $111,063.15 |
DisclosureSEC source: 0000784199-20-000065 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,448 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:14 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 19,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000065 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,903 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:13 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 734 | $24.93 | $18,298.62 |
DisclosureSEC source: 0000784199-20-000063 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,305 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:13 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 4,874 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000063 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,039 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:11 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 385 | $24.93 | $9,598.05 |
DisclosureSEC source: 0000784199-20-000061 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,234 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:11 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 2,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000061 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,619 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:10 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 615 | $24.93 | $15,331.95 |
DisclosureSEC source: 0000784199-20-000059 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,888 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:10 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 4,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000059 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,503 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:08 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 615 | $24.93 | $15,331.95 |
DisclosureSEC source: 0000784199-20-000057 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,072 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:08 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 4,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000057 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,687 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:07 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 350 | $24.93 | $8,725.50 |
DisclosureSEC source: 0000784199-20-000055 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,237 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:07 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 2,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000055 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,587 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:05 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
Tax withholdingCommon Stock | 911 | $24.93 | $22,711.23 |
DisclosureSEC source: 0000784199-20-000053 · certent-form4.xml · nonDerivative · entry 2 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,788 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:05 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
GrantCommon Stock | 4,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000053 · certent-form4.xml · nonDerivative · entry 1 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,699 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:38 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 4,734 | $26.05 | $123,339.64 |
DisclosureSEC source: 0000784199-20-000051 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,865 F1 · price: Reflects weighted average price. Range of prices were between $24.05 to $26.08. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:37 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 3,157 | $26.20 | $82,713.40 |
DisclosureSEC source: 0000784199-20-000049 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,147 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:37 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000049 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,304 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:37 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 6,842 | $26.20 | $179,260.40 |
DisclosureSEC source: 0000784199-20-000049 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,304 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:36 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 618 | $26.20 | $16,191.60 |
DisclosureSEC source: 0000784199-20-000047 · certent-form4.xml · nonDerivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,165 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:36 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 4,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000047 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,783 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:36 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 2,869 | $26.20 | $75,167.80 |
DisclosureSEC source: 0000784199-20-000047 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,683 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:34 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 339 | $26.20 | $8,881.80 |
DisclosureSEC source: 0000784199-20-000045 · certent-form4.xml · nonDerivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,065 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:34 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000045 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,404 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:34 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,718 | $26.20 | $45,011.60 |
DisclosureSEC source: 0000784199-20-000045 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,104 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:33 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 511 | $26.20 | $13,388.20 |
DisclosureSEC source: 0000784199-20-000043 · certent-form4.xml · nonDerivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,419 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:33 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 3,390 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000043 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,930 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:33 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 2,269 | $26.20 | $59,447.80 |
DisclosureSEC source: 0000784199-20-000043 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,540 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:30 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 292 | $26.20 | $7,650.40 |
DisclosureSEC source: 0000784199-20-000039 · certent-form4.xml · nonDerivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,267 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:30 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000039 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,559 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:30 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 1,510 | $26.20 | $39,562.00 |
DisclosureSEC source: 0000784199-20-000039 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,561 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.